SRx Health Solutions (SRXH) EBIT (2010 - 2025)

SRx Health Solutions has reported EBIT for 16 years, with the latest figure at -$17.4 million in Q2 2025.

• For the quarter ending Q2 2025, EBIT fell 1217.85% year-over-year to -$17.4 million; the trailing twelve-month figure through Jun 2025 stood at -$11.1 million (up 41.83% YoY), and the FY2025 full-year result was -$3.8 million, down 190.41% from the prior year.
• EBIT for Q2 2025 stood at -$17.4 million, down from -$1.1 million in the prior quarter.
• The five-year high for EBIT was $8.5 million in Q4 2024, with the low at -$24.2 million in Q4 2022.
• Historically, EBIT has averaged -$5.1 million across 5 years, with a median of -$3.6 million in 2022.
• Annual changes were most pronounced in 2024 — EBIT surged 166.89% — and 2025, when it tumbled 1217.85%.
• SRx Health Solutions' EBIT stood at -$5.0 million in 2021, then sank by 385.37% to -$24.2 million in 2022, then surged by 47.33% to -$12.7 million in 2023, then surged by 166.89% to $8.5 million in 2024, then sank by 304.72% to -$17.4 million in 2025.
• The last three EBIT figures came in at -$17.4 million (Q2 2025), -$1.1 million (Q1 2025), and $8.5 million (Q4 2024), per Business Quant data.